Early Access — free while we kick the tires
EdgarHawk

Bassler Bonnie L

Director

Director
1 filing analyzed · 1 company · Latest 2026-01-08

Companies

Company Buys Sells Direction
REGENERON PHARMACEUTICALS, INC. REGN 0 2 Net selling

Activity

January 2026
medium
Sell
1,500 shares
$1,200,000
Significance 5/10

Director Bonnie L Bassler sold 1,500 shares of REGN at $800.00 (1.2M total); held 3,203 pre-sale, 1,703 post-sale (-46.8%).

Director Bonnie L Bassler sold 1,500 shares at $800.00 on 2026-01-07, reducing her holdings from 3,203 to 1,703 shares, a 46.8% reduction in position. The sale occurred near the upper end of the 52-week range ($483.07–$812.27) and within 1.4% of the 52-week high, while the stock has appreciated 41.9% over 90 days and 15.7% over 30 days. The company maintains solid fundamentals with $3.8B quarterly revenue, $1.5B net income, and a reasonable 16.44 P/E valuation, though annual revenue growth of 8.3% reflects a moderating growth trajectory. This substantial reduction in a director's stake merits disclosure scrutiny, though the absence of a scheduled trading plan flag and the concentrated nature of the transaction (single sale) warrant examination of context and intent.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access